CEL-SCI CORPORATION Adjustments to Additional Paid in Capital, Warrant Issued
CEL-SCI CORPORATION (CVM) reported Adjustments to Additional Paid in Capital, Warrant Issued of $291.23 thousand for the 3-month period ending 2018-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2019-08-14
- CEL-SCI CORPORATION adjustments to additional paid in capital, warrant issued for the quarter ending 2018-06-30 was $291.23K.
- CEL-SCI CORPORATION adjustments to additional paid in capital, warrant issued for the quarter ending 2013-09-30 was $0.00.
- CEL-SCI CORPORATION adjustments to additional paid in capital, warrant issued for the quarter ending 2013-06-30 was $0.00.
- CEL-SCI CORPORATION adjustments to additional paid in capital, warrant issued for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- CEL-SCI CORPORATION adjustments to additional paid in capital, warrant issued for fiscal 2013 was $0.00.
- CEL-SCI CORPORATION adjustments to additional paid in capital, warrant issued for fiscal 2012 was -$1.59M.
- CEL-SCI CORPORATION adjustments to additional paid in capital, warrant issued for fiscal 2011 was $0.00.
- CEL-SCI CORPORATION adjustments to additional paid in capital, warrant issued for fiscal 2010 was -$1.53M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2018-06-30 | $291.23K 10-Q · filed 2019-08-14 | |||
| 2013-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-27 | $0.00 derived: sum of 2 quarters · filed 2013-12-27 | $0.00 10-K · filed 2013-12-27 | |
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | ||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-10 | |||
| 2012-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-27 | $0.00 derived: sum of 2 quarters · filed 2013-12-27 | -$1.59M 10-K · filed 2013-12-27 | |
| 2012-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-09 | -$1.59M 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | -$1.59M 10-Q · filed 2013-05-10 | |||
| 2011-09-30 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-27 | $0.00 10-K · filed 2013-12-27 | ||
| 2011-06-30 | -$1.07M 10-Q · filed 2011-08-09 | |||
| 2010-09-30 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-23 | -$1.53M 10-K · filed 2011-12-23 | ||
| 2010-06-30 | -$1.43M 10-Q · filed 2011-08-09 | |||
| 2009-09-30 | -$24.06K 10-K · filed 2011-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |